Insufficient Sleep Syndrome
11
1
1
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
2 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (11)
Biomarkers of Increased Free Living Sleep Time
Improving Outcomes for Patients With SDB and Insufficient Sleep
Effect of Sleep Extension on Ceramides in People with Overweight and Obesity
Impact of Beds for Kids Program on Child Sleep
Metabolomics-based Sleepiness Markers
Pilot Study Comparing the Effectiveness of Two Different Methods of Acoustic Stimulation
A Study of the Effectiveness and Efficacy of the PowerSleep Device
Biomarkers of Insufficient Sleep and Sleepiness
Evaluation of the Reliability and Validity of a Diagnostic Sleep Disorders Questionnaire
Smart Sleep In-home Validation Extension Study
Sleep Duration Required to Restore Performance During Chronic Sleep Restriction